News & Media
Take a closer look at what we’re doing across Teva worldwide
Press releases
Feb 19 / 2019
Teva Finalizes Settlement with Federal Trade Commission to Resolve All Outstanding Litigation between the Parties
Feb 15 / 2019
Statement: AJOVY® (fremanezumab-vfrm) injection Access Update
Feb 6 / 2019
Teva Announces U.S. Launch of a Generic Version of Sabril® (Vigabatrin)
The first generic version of Sabril® (vigabatrin) tablets to enter the US market.
Top Stories
Read the latest Teva news
Uncovering Insights on Multiple Chronic Conditions
Narrative review represents a key milestone in Teva’s efforts to address multiple chronic conditions
Teva deploys new 2D barcode in fight against counterfeit drug market
The counterfeit drugs trade is thought to be the world’s largest fraud market, with billions of dollars making its way into the hands of organized crime gangs each year
Teva USA Named a Best Employer for Healthy Lifestyles
Our health and wellness benefits are officially award-winning — improving health not only for patients, but also for our employees and their families
